Gonococcal & Nongonococcal Urethritis MCQ Quiz | Sexually Transmitted Infections

Welcome to this specialized quiz on Gonococcal and Nongonococcal Urethritis, a critical topic within Sexually Transmitted Infections for MBBS students. This quiz is designed to test your understanding of the etiology, clinical presentation, diagnosis, management, and complications of these common conditions. You will encounter 25 multiple-choice questions that reflect the level of detail expected in your professional examinations. This exercise will help you consolidate your knowledge and identify areas for further study. After submitting your answers, you will see your score and a detailed review of each question. For your convenience and future revision, you can also download all the questions along with their correct answers in a PDF format. Good luck!

1. What is the most common identifiable cause of nongonococcal urethritis (NGU) in males?

2. A Gram stain of urethral discharge from a patient with gonococcal urethritis (GU) will typically show which microscopic finding?

3. A 24-year-old male presents with a copious, purulent, yellow-green urethral discharge and severe dysuria that began 3 days after unprotected sexual intercourse. This clinical presentation is most suggestive of:

4. According to current CDC guidelines, what is the recommended first-line treatment for uncomplicated urogenital gonorrhea?

5. What is the recommended first-line treatment for NGU when Chlamydia trachomatis is the confirmed or suspected pathogen?

6. The most sensitive and specific diagnostic test for both N. gonorrhoeae and C. trachomatis from a first-void urine sample is:

7. Disseminated Gonococcal Infection (DGI) classically presents as a triad of:

8. A common and significant complication of untreated chlamydial urethritis in men is:

9. Which of the following features is more characteristic of gonococcal urethritis compared to nongonococcal urethritis?

10. Chlamydia trachomatis, a common cause of NGU, is best described as:

11. A patient with NGU is treated with doxycycline but returns with persistent symptoms. Re-infection is ruled out. Which organism is a major cause of persistent/recurrent NGU and should be tested for?

12. A male patient is diagnosed and treated for uncomplicated gonococcal urethritis. What is the most appropriate advice regarding his sexual partner(s) from the last 60 days?

13. In a resource-limited setting using a syndromic management approach, a male patient presenting with urethral discharge should receive empiric treatment that covers:

14. Thayer-Martin medium is a selective agar specifically designed for the culture of:

15. The typical incubation period for symptomatic gonococcal urethritis is:

16. Compared to gonococcal urethritis, the incubation period for chlamydial urethritis is typically:

17. Which of the following statements is true regarding asymptomatic urethritis?

18. On a urethral smear Gram stain, the presence of >5 polymorphonuclear leukocytes (PMNs) per oil immersion field without visible intracellular diplococci is a presumptive diagnosis for:

19. A patient treated for NGU with doxycycline has persistent symptoms. A test for Mycoplasma genitalium is positive and shows macrolide resistance. What is the recommended treatment?

20. A patient develops urethritis, conjunctivitis, and arthritis following a genital infection. This triad is characteristic of:

21. Untreated chlamydial or gonococcal infection in a female partner of a man with urethritis is a leading cause of what serious condition?

22. The urethral inflammation and discharge in these infections are primarily mediated by:

23. Besides treatment and partner notification, what is a key public health measure for controlling the spread of both GU and NGU?

24. A male patient presents with mild dysuria and a scanty, clear urethral discharge for the past two weeks. Which diagnosis is most likely?

25. What is meant by “expedited partner therapy” (EPT)?